Hebei Changshan Biochemical Pharmaceutical Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 1,194

Employees

  • Stock Symbol
  • 300255

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $2.37
  • (As of Friday Closing)

Hebei Changshan Biochemical Pharmaceutical General Information

Description

Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the Research, development, production and sales of heparin products.

Contact Information

Website
www.hbcsbio.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • No. 71 Menglong Street
  • South District, Shijiazhuang
  • Hebei, ZhengDing 050800
  • China
+86 0311
Primary Industry
Medical Supplies
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • No. 71 Menglong Street
  • South District, Shijiazhuang
  • Hebei, ZhengDing 050800
  • China
+86 0311

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hebei Changshan Biochemical Pharmaceutical Stock Performance

As of 20-Nov-2026, Hebei Changshan Biochemical Pharmaceutical’s stock price is $2.37. Its current market cap is $2.18B with 919M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.37 $2.53 $2.37 - $9.92 $2.18B 919M 18.6M -$0.06

Hebei Changshan Biochemical Pharmaceutical Financials Summary

As of 30-Sep-2026, Hebei Changshan Biochemical Pharmaceutical has a trailing 12-month revenue of $135M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 3,527,729 8,474,922 2,787,971 1,982,164
Revenue 134,966 121,693 143,658 199,359
EBITDA (34,315) (26,537) (11,750) (150,168)
Net Income (50,920) (49,768) (34,768) (175,298)
Total Assets 640,857 621,892 619,548 648,429
Total Debt 387,179 360,758 339,858 328,216
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hebei Changshan Biochemical Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hebei Changshan Biochemical Pharmaceutical‘s full profile, request access.

Request a free trial

Hebei Changshan Biochemical Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hebei Changshan Biochemical Pharmaceutical Investments & Acquisitions (3)

Hebei Changshan Biochemical Pharmaceutical’s most recent deal was a Secondary Transaction - Private with Changshan Biochem Pharm (Jiangsu) for . The deal was made on 24-Nov-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Changshan Biochem Pharm (Jiangsu) 24-Nov-2017 Secondary Transaction - Private Pharmaceuticals
Changshan Kaijiejian Biopharmaceutical R&D (Hebei) 25-Dec-2012 Joint Venture Discovery Tools (Healthcare)
Changshan Biochem Pharm (Jiangsu) 01-Mar-2012 Merger/Acquisition Pharmaceuticals
To view Hebei Changshan Biochemical Pharmaceutical’s complete investments and acquisitions history, request access »

Hebei Changshan Biochemical Pharmaceutical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Hebei Changshan Biochemical Pharmaceutical’s complete esg history, request access »

Hebei Changshan Biochemical Pharmaceutical Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Changshan Biochem Pharm (Jiangsu) Changzhou, China 1997
Hebei Changshan Pharmaceutical

Hebei Changshan Biochemical Pharmaceutical FAQs

  • When was Hebei Changshan Biochemical Pharmaceutical founded?

    Hebei Changshan Biochemical Pharmaceutical was founded in 2000.

  • Where is Hebei Changshan Biochemical Pharmaceutical headquartered?

    Hebei Changshan Biochemical Pharmaceutical is headquartered in Hebei, China.

  • What is the size of Hebei Changshan Biochemical Pharmaceutical?

    Hebei Changshan Biochemical Pharmaceutical has 1,194 total employees.

  • What industry is Hebei Changshan Biochemical Pharmaceutical in?

    Hebei Changshan Biochemical Pharmaceutical’s primary industry is Medical Supplies.

  • Is Hebei Changshan Biochemical Pharmaceutical a private or public company?

    Hebei Changshan Biochemical Pharmaceutical is a Public company.

  • What is Hebei Changshan Biochemical Pharmaceutical’s stock symbol?

    The ticker symbol for Hebei Changshan Biochemical Pharmaceutical is 300255.

  • What is the current stock price of Hebei Changshan Biochemical Pharmaceutical?

    As of 20-Nov-2026 the stock price of Hebei Changshan Biochemical Pharmaceutical is $2.37.

  • What is the current market cap of Hebei Changshan Biochemical Pharmaceutical?

    The current market capitalization of Hebei Changshan Biochemical Pharmaceutical is $2.18B.

  • What is Hebei Changshan Biochemical Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Hebei Changshan Biochemical Pharmaceutical is $135M.

  • What is Hebei Changshan Biochemical Pharmaceutical’s annual earnings per share (EPS)?

    Hebei Changshan Biochemical Pharmaceutical’s EPS for 12 months was -$0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process